Drug Type Peptide Conjugate Radionuclide, Therapeutic radiopharmaceuticals |
Synonyms- |
Target |
Mechanism SSTR2 modulators(Somatostatin receptor 2 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | CH | 25 Aug 2016 | |
Neuroendocrine Tumors | Preclinical | CH | 25 Aug 2016 | |
Renal Cell Carcinoma | Preclinical | CH | 25 Aug 2016 | |
Thyroid Cancer, Medullary | Preclinical | CH | 25 Aug 2016 |